“First episode was great, interesting questions raised - my view: big pharma should have a “catch up” mechanism where a % of initial sales goes into repaying public money invested in development spend directly attributable to a specific drug. Once public money is repaid, pharma should be free to do as they wish (they are still accountable to stakeholders, financial and non-financial, so price gouging has it’s limits!)”
Rammer K via Apple Podcasts ·
Canada ·
12/01/20